Mankind Pharma collaborates with OpenAI to drive AI-enabled transformation across value chain
The goal is to deliver greater value to customers, doctors, and the broader healthcare ecosystem
The goal is to deliver greater value to customers, doctors, and the broader healthcare ecosystem
MKP11093 has shown strong results in preclinical studies with a promising safety and selectivity profile
Mangalam Drugs and Organics receives repeat export order worth $ 21, 81,040
The company has posted net profit of Rs. 1,986.43 crores for the Financial Year ended March 31, 2025
The camp, operational daily from 12 PM to 4 PM, offers free health check-ups, blood pressure monitoring
Q3 FY25 revenue up 24% to Rs 3,230 crore
Alankit will undertake the verification of pending e-KYC enrollments through the Beneficiary Identification System (BIS) platform provided by the National Health Authority (NHA).
Mankind Pharma will have exclusive rights to register, import, market, sell and distribute sintilimab in India
Revenue from Operations during Q2 FY25 was Rs. 3,077 crore as compared to Rs. 2,708 crore in Q2 FY24.
Subscribe To Our Newsletter & Stay Updated